Echoes of Cabrini-Green

“Rudolph Elliot Willis takes readers on an inspirational, personal journey that will both compel us to tears and encourage us to make the world a better place.“— Raj Tawney, author of Colorful Palate: A Flavorful Journey Through a Mixed American Experience

“A poignant and deeply personal account of African American migration, struggle, and resilience in post-WWII Chicago. Willis powerfully illustrates how broader social forces, such as racism, deindustrialization, and poverty, shaped the lives of families such as his, while also honoring the moments of joy, humor, and hope that persisted.“—Teresa Irene Gonzales, author of Building a Better Chicago: Race and Community Resistance to Urban Redevelopment

“Dr. Rudolph Elliot Willis puts a face on poverty in his compelling coming-of-age memoir recounting his life’s improbable path from a notorious Chicago housing project to becoming a molecular geneticist at the prestigious National Cancer Institute.“—Edmund O. Lawler, author of The Graft: How a Pioneering Operation Sparked the Modern Age of Organ Transplants

“This book is not just a memoir—it is an epistolary archival act and tribute to a mother’s love, to the bonds of family, and to the unbreakable spirit that allows us not only to survive, but to hope. Willis masterfully gathers fragments of memory, the wisdom once written to him in his mother’s lost letters, and the voices of community to create a moving record of life shaped by Chicago’s Cabrini-Green Homes. Through remembered and reimagined letters, Dr. Willis honors his mother’s unwavering support, wisdom, and sacrifices that shaped and guided his path from childhood poverty to personal and professional success.“—Jessica C. Neal, Vanguard Archives Consulting

Rudolph Elliot Willis is an oncologist and internal medicine specialist with over three decades of experience in clinical oncology, cancer research, and molecular biology. Dr. Willis worked as a researcher at the NIH National Cancer Institute and founded Oncova Biosciences, an AI-based biotech cancer drug discovery company. He is an attending physician at the University of Maryland Medical System.